Document is current
Any future updates will be listed below
-
Authors
Steffen, Gyde
Krings, Amrei
Guttmann, Sarah
Lübke, Nadine
Meyer-Schlinkmann, Kristin
Tiemann, Carsten
Timm, Jörg
Walker, Andreas
Zimmermann, Ruth
,
Backmund, Markus
Dorsch, Hans-Peter
Bayer, Sebastian
Ciomber, Jörg
Gerlich, Miriam
Leicht, Astrid
Kießling, Martin
Neumeier, Esther
Nielsen, Stine
Rensmann, Willehad
Schäffer, Dirk
Ostermann, Olaf
Stöter, Christiane
Wiedemann, Stefan
Wimmer, Katrin
-
Funding
Funding for this research was provided by:
Bundesministerium für Gesundheit (520AUK701, 520AUK701, 520AUK701, 520AUK701, 520AUK701, 520AUK701)
Robert Koch-Institut
- License Information
-
More Information
Article History
Received: 12 July 2024
Accepted: 1 November 2024
First Online: 20 December 2024
Declarations
:
: Ethical approval for the DRUCK 2.0 study, including the evaluation, was provided by the Medical Chamber Berlin (ETH-51/10). All participants signed a written consent.
: Not applicable.
: DRUCK 2.0 study group: Condrobs e.V., employer of Olaf Ostermann, cooperates with Abbvie and Gilead. No conflict of interest declared by the other study group members.
